Literature DB >> 13916396

A multiple catheter technique for studies of hepatic metabolism and blood flow in dogs with portacaval transposition.

T E STARZL, R E LAZARUS, L SCHLACHTER, F H THORNTON, R M WENDEL, B STEARN, W A SCANLON.   

Abstract

Entities:  

Keywords:  CATHETERIZATION; LIVER FUNCTION TESTS

Mesh：

Year:  1962        PMID： 13916396

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  6 in total

1.  A COMPARISON OF THE HYPOGLYCEMIC EFFECT OF INSULIN WITH SYSTEMIC VENOUS AND PORTAL VENOUS ADMINISTRATION.

Authors:  T E STARZL; W A SCANLAN; H M YANOF; F H THORNTON; R M WENDEL; B STEARN; R E LAZARUS; W MCALLISTER; W C SHOEMAKER
Journal:  J Surg Res       Date:  1963-08       Impact factor: 2.192

2.  EFFECT OF INSULIN ON GLUCOSE METABOLISM IN THE DOG AFTER PORTACAVAL TRANSPOSITION.

Authors:  T E Tarzl; W A Scanlan; F H Thornton; R M Wendel; B Stearn; R E Larzarus\; W McAllister; W C Shoemaker
Journal:  Am J Physiol       Date:  1965-07

3.  Studies on hepatic blood flow and the rate of bromsulphalein clearance in dogs with portacaval transposition.

Authors:  T E STARZL; W A SCANLON; W C SHOEMAKER; F H THORNTON; R M WENDEL; L SCHLACHTER
Journal:  Surgery       Date:  1962-10       Impact factor: 3.982

4.  [Quantitative determination of hepatic metabolism in the unanesthetized, free, mobile rabbit].

Authors:  F Müller
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1967

5.  Oxygen and CO-2 content in the splanchnic and nonsplanchnic blood of dogs with portacaval transposition.

Authors:  T J Herrmann; P D Taylor; T L Marchioro; T E Starzl
Journal:  Surgery       Date:  1966-12       Impact factor: 3.982

6.  Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate.

Authors:  T Sakamoto; M Fujimura; J Newman; X G Zhu; G H Greeley; J C Thompson
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.